Thomas G Martin

Years Active: 2021-2023
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Thomas G Martin, Maria Victoria Mateos, Ajay K Nooka, Arnob Banerjee, Rachel Kobos, Lixia Pei, Ming Qi, Raluca Verona, Margaret Doyle, Jennifer Smit, Weili Sun, Danielle Trancucci, Clarissa Uhlar, Niels W C J van de Donk, Cesar Rodriguez
Detailed overview of incidence and management of cytokine release syndrome observed with teclistamab in the MajesTEC-1 study of patients with relapsed/refractory multiple myeloma. Cancer (2023)
Ajay K Nooka, Cesar Rodriguez, María Victoria Mateos, Salomon Manier, Katherine Chastain, Arnob Banerjee, Rachel Kobos, Keqin Qi, Raluca Verona, Margaret Doyle, Thomas G Martin, Niels W C J van de Donk
Incidence, timing, and management of infections in patients receiving teclistamab for the treatment of relapsed/refractory multiple myeloma in the MajesTEC-1 study. Cancer (2023)
Thomas G Martin, Nina Shah, Joshua Richter, David H Vesole, Sandy W Wong, Chiung-Yu Huang, Deepu Madduri, Sundar Jagannath, David S Siegel, Noa Biran, Jeffrey L Wolf, Samir Parekh, Hearn J Cho, Pamela Munster, Shambavi Richard, Samira Ziti-Ljajic, Ajai Chari
Phase 1b trial of isatuximab, an anti-CD38 monoclonal antibody, in combination with carfilzomib as treatment of relapsed/refractory multiple myeloma. Cancer 127 (11) (2021)

Thomas G Martin.css-eqlu8i{font-size:small;padding-left:4px;}